Psychosis spectrum disorders represent a complex, heterogeneous array of neuropsychiatric conditions that challenge classical categorical diagnostic systems. Emerging neuroimaging evidence demonstrates that cerebral perfusion alterations reflect underlying pathophysiological variations across schizophrenia, schizoaffective disorder, and psychotic bipolar disorder. Historically, clinical psychiatry has relied primarily on subjective phenomenological assessments to distinguish clinical phenotypes. However, functional hemodynamic investigations using arterial spin labeling now provide quantitative insights into regional neurovascular coupling. By evaluating resting-state cerebral blood flow across large patient cohorts, neuroscientists can identify biologically distinct subgroups that surpass traditional symptom-based diagnostic boundaries.

Consequently, objective neuroimaging biomarkers offer an unprecedented avenue to enhance diagnostic stratification and individualized management in clinical psychiatry. A landmark study evaluating pseudo-continuous arterial spin labeling scans across thousands of participants reveals widespread cerebral blood flow abnormalities. These physiological signatures not only delineate patients from neurotypical controls but also distinguish biologically informed biotypes derived from neurophysiological clustering. Understanding the neurovascular architecture underlying psychosis is pivotal for clinicians seeking to translate advanced neuroimaging insights into actionable diagnostic frameworks.

Mechanisms of Cerebral Perfusion Alterations in Psychosis

Cerebral blood flow serves as an indirect yet highly reliable metric of localized metabolic demand and synaptic activity within the central nervous system. Because microvascular regulation is tightly coupled to neuronal signaling, persistent regional cerebral perfusion alterations indicate localized neurovascular dysregulation or altered metabolic processing. In psychosis spectrum disorders, aberrant glutamatergic neurotransmission and cortical GABAergic interneuron dysfunction disrupt normal physiological coupling. When inhibitory interneurons fail to regulate pyramidal cell firing, localized downstream vascular responses shift markedly. This decoupling frequently manifests as altered resting-state hemodynamics across key association cortices.

Furthermore, microvascular endothelial inflammation, oxidative stress, and chronic neurochemical imbalances contribute substantially to long-term hemodynamic shifts. Investigations leveraging pseudo-continuous arterial spin labeling enable non-invasive, contrast-free quantification of total gray matter and regional cerebral blood flow. By mitigating radiation exposure and gadolinium toxicity, this functional modality accurately captures microvascular variations across deep subcortical nuclei and superficial neocortical ribbons. These physiological measurements underscore that psychotic illnesses are not purely functional disturbances but reflect distinct vascular and metabolic perturbations.

Biomarker Mapping Across Phenotypes and Biotypes

Traditional psychiatric classifications often conflate clinically divergent pathologies under overlapping diagnostic umbrellas. To address this limitation, the Bipolar-Schizophrenia Network on Intermediate Phenotypes established biologically informed biotypes using neurophysiological clustering, cognitive panels, and structural metrics. When examining resting-state hemodynamics, researchers observed significant reductions in total gray matter cerebral blood flow among patients compared with neurotypical controls. Interestingly, this widespread hypoperfusion was markedly pronounced in individuals diagnosed with psychotic bipolar disorder and those classified within Biotype 1, representing the most biologically severe neurophysiological subgroup.

Specifically, individuals categorized under Biotype 1 and psychotic bipolar disorder exhibited significant hypoperfusion across 25 distinct regions, spanning bilateral temporal, occipital, and inferior frontal cortices, alongside selected subcortical nuclei. In contrast, patients with classic schizophrenia and schizoaffective disorder demonstrated intermediate hemodynamic profiles. Crucially, these biological biotypes yielded larger effect sizes regarding perfusion deficits than conventional Diagnostic and Statistical Manual classifications alone. Therefore, biotype-informed categorization highlights distinct neurovascular endophenotypes that can effectively stratify heterogeneous patient cohorts into coherent, pathophysiologically grounded subgroups.

Regional Hyperperfusion and Clinical Symptom Severity

Although baseline cortical hypoperfusion characterizes severe biological subgroups, paradoxical focal hyperperfusion correlates directly with acute symptom expression within psychosis spectrum disorders. Recent quantitative analyses demonstrate that higher total gray matter cerebral blood flow is positively associated with greater psychotic symptom severity. In particular, marked hyperperfusion localized to the right superior temporal sulcus closely tracks with escalated psychotic, manic, and depressive scores. This regional hyperactivation illustrates that acute psychopathology may trigger localized hypermetabolic states amidst a broader background of chronic resting-state hypoperfusion.

The superior temporal sulcus serves as an integral node for social cognition, audio-visual integration, and voice processing. Hyperactivity and hyperperfusion within this region likely destabilize auditory-perceptual networks, contributing to sensory delusions and auditory verbal hallucinations. Similarly, adjacent temporal structures govern affective balance, explaining the co-occurrence of manic and depressive states when metabolic balance falters. Thus, regional perfusion shifts reflect the dynamic state of active clinical symptomatology rather than mere static trait-related neuroarchitectural deficits.

Cognitive Dimensions and Methodological Advancements

Intriguingly, while cerebral perfusion changes correlate robustly with positive and affective symptom dimensions, current investigations report no statistically significant associations between resting-state cerebral blood flow and generalized cognitive performance. Cognitive deficits across the psychosis spectrum likely reflect deep structural disconnectivity, synaptic pruning abnormalities, and white matter tract degradation rather than instantaneous microvascular fluctuations. Consequently, resting-state perfusion primarily tracks transient psychotic states and underlying neurovascular tone rather than enduring neurocognitive impairment.

From a methodological perspective, the integration of automated image-processing pipelines like ExploreASL and FreeSurfer has transformed large-scale neuroimaging research. By automating structural segmentation, motion correction, and region-of-interest extraction across 60 brain regions, these sophisticated analytical toolboxes substantially minimize inter-site variability. Robust multi-site harmonization ensures reproducible quantification of arterial blood water spins, enabling massive meta-cohort studies involving thousands of patients. These rigorous analytical advances provide the reproducibility required to position perfusion MRI as a viable clinical biomarker candidate.

Translational Horizons for Precision Psychiatry

The translation of hemodynamic neuroimaging into standard psychiatric care holds transformative potential for targeted therapeutics. Identifying specific biotypes exhibiting widespread hypoperfusion could guide clinicians toward vascular, metabolic, or neuroprotective interventions tailored to rescue compromised neuronal circuits. Conversely, patients presenting with localized hyperperfusion in temporal circuits might benefit more selectively from rapid symptom-stabilizing dopamine receptor antagonists or targeted non-invasive neuromodulation therapies. Stratifying clinical trials based on baseline neurovascular profiles could also optimize drug discovery by reducing sample heterogeneity.

Nevertheless, widespread clinical adoption requires standardized reference ranges across diverse global demographics and routine MRI platforms. Currently, advanced neuroimaging tools complement rather than replace longitudinal clinical evaluations and comprehensive psychiatric interviews. As precision psychiatry evolves, combining resting-state perfusion imaging with genomics, electrophysiology, and deep clinical phenotyping will bridge the gap between subjective symptom clusters and precise biological diagnoses, ultimately improving outcomes for individuals living with complex psychotic disorders.

Frequently Asked Questions

What causes cerebral perfusion alterations in psychotic disorders?

Cerebral perfusion alterations stem from disrupted neurovascular coupling driven by abnormal glutamatergic signaling, GABAergic interneuron dysfunction, and localized microvascular neuroinflammation. These underlying biochemical shifts alter regional metabolic demand and resting blood flow across neocortical and subcortical structures.

How do neurobiological biotypes differ from traditional psychiatric diagnoses?

Neurobiological biotypes classify individuals using objective biomarkers, such as neurophysiological testing, cognitive assessments, and brain imaging patterns, rather than purely descriptive clinical symptoms. This biological clustering captures underlying pathophysiology more reliably than traditional DSM-based diagnostic categories.

Does cerebral blood flow correlate with cognitive deficits in psychosis?

Large-scale arterial spin labeling studies reveal no significant correlation between resting-state cerebral blood flow and cognitive performance. While perfusion tracks clinical symptom severity, cognitive impairment in psychosis appears driven by structural network dysconnectivity and permanent synaptic alterations.

Disclaimer: This content is for informational and educational purposes only and does not constitute formal medical advice, diagnosis, or treatment planning. Healthcare professionals must exercise independent clinical judgment and correlate imaging findings with comprehensive clinical assessments. Refer to the latest local and national guidelines for clinical practice.

References

Hoang D et al. Cerebral perfusion alterations are associated with clinical phenotypes and biotypes across the psychosis spectrum. Psychol Med. 2026 Sep 24. doi: 10.1017/S0033291726105844. PMID: 42779463.

Mutsaerts HJ et al. ExploreASL: An image processing pipeline for multi-center ASL perfusion MRI studies. Neuroimage. 2020;219:117031. doi: 10.1016/j.neuroimage.2020.117031.

Clementz BA et al. Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers. Am J Psychiatry. 2016;173(4):373-384. doi: 10.1176/appi.ajp.2015.14091200.